• 568 Citations
  • 9 h-Index
20002019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Dana J. Lukin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Inflammatory Bowel Diseases Medicine & Life Sciences
Ulcerative Colitis Medicine & Life Sciences
Crohn Disease Medicine & Life Sciences
Immunosuppressive Agents Medicine & Life Sciences
Safety Medicine & Life Sciences
Eosinophilic Esophagitis Medicine & Life Sciences
Tumor Necrosis Factor-alpha Medicine & Life Sciences
Ankyrins Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2000 2019

  • 568 Citations
  • 9 h-Index
  • 20 Article

Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors

Agrawal, M., Cohen-Mekelburg, S., Kayal, M., Axelrad, J., Galati, J., Tricomi, B., Kamal, K., Faye, A. S., Abrudescu, P., Scherl, E., Lawlor, G., Sultan, K., Lukin, D. J., Colombel, J. F. & Ungaro, R. C., Jan 1 2019, (Accepted/In press) In : Alimentary Pharmacology and Therapeutics.

Research output: Contribution to journalArticle

Inflammatory Bowel Diseases
Economics
Odds Ratio
Confidence Intervals
Hispanic Americans

Escalation of immunosuppressive therapy for inflammatory bowel disease is not associated with adverse outcomes after infection with clostridium difficile

Lukin, D. J., Lawlor, G., Hudesman, D. P., Durbin, L., Axelrad, J. E., Passi, M., Cavaliere, K., Coburn, E., Loftus, M., Jen, H., Feathers, A., Rosen, M. H., Malter, L. B. & Swaminath, A., Mar 14 2019, In : Inflammatory Bowel Diseases. 25, 4, p. 775-781 7 p.

Research output: Contribution to journalArticle

Clostridium Infections
Clostridium difficile
Immunosuppressive Agents
Inflammatory Bowel Diseases
Infection

Intestinal Spirochetosis Resembles Inflammatory Bowel Disease in a Patient With HIV Infection

Agrawal, M., Zhang, W. & Lukin, D. J., Jan 1 2019, (Accepted/In press) In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

Inflammatory Bowel Diseases
HIV Infections
1 Citation (Scopus)

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases

Meserve, J., Aniwan, S., Koliani-Pace, J. L., Shashi, P., Weiss, A., Faleck, D., Winters, A., Chablaney, S., Kochhar, G., Boland, B. S., Singh, S., Hirten, R., Shmidt, E., Hartke, J. G., Chilukuri, P., Bohm, M., Sagi, S. V., Fischer, M., Lukin, D. J., Hudesman, D. & 13 others, Chang, S., Gao, Y., Sultan, K., Swaminath, A., Gupta, N., Kane, S., Loftus, E. V., Shen, B., Sands, B. E., Colombel, J. F., Siegel, C. A., Sandborn, W. J. & Dulai, P. S., Jul 1 2019, In : Clinical Gastroenterology and Hepatology. 17, 8, p. 1533-1540.e2

Research output: Contribution to journalArticle

Open Access
Inflammatory Bowel Diseases
Safety
Odds Ratio
Immunosuppressive Agents
Infection
1 Citation (Scopus)

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis

Faleck, D. M., Winters, A., Chablaney, S., Shashi, P., Meserve, J., Weiss, A., Aniwan, S., Koliani-Pace, J. L., Kochhar, G., Boland, B. S., Singh, S., Hirten, R., Shmidt, E., Kesar, V., Lasch, K., Luo, M., Bohm, M., Varma, S., Fischer, M., Hudesman, D. & 14 others, Chang, S., Lukin, D. J., Sultan, K., Swaminath, A., Gupta, N., Siegel, C. A., Shen, B., Sandborn, W. J., Kane, S., Loftus, E. V., Sands, B. E., Colombel, J. F., Dulai, P. S. & Ungaro, R., Jan 1 2019, In : Clinical Gastroenterology and Hepatology.

Research output: Contribution to journalArticle

Open Access
Ulcerative Colitis
Crohn Disease
Adrenal Cortex Hormones
vedolizumab
Tumor Necrosis Factor-alpha